Summary
Serum prolactin (PRL), luteinizing hormone (LH) and testosterone (T) levels were estimated in a group of 30 male paranoid schizophrenics before and after 4 weeks treatment with chlorpromazine and/or trihexyphenidyl, and in a group of 14 healthy male individuals. After treatment with chlorpromazine (100 mg t.i.d., p. o.), 10 patients presented a significant increase in serum PRL values and a significant decrease in serum T values. A significant increase in serum PRL values was also found in 10 patients who were treated with chlorpromazine (100 mg t.i.d., p. o.) plus trihexyphenidyl (5 mg t.i.d., p. o.). No significant difference in any of the investigated endocrine parameters was detected in 10 patients after 4 weeks administration of trihexyphenidyl (5mg t.i.d., p.o.). Following chlorpromazine treatment with or without concomitant administration of trihexyphenidyl, 20 patients showed a significant increase in serum PRL levels and a significant decrease in serum LH and T levels.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Anden NE, Butcher SG, Corrodi H, Fuxe K, Ungerstedt U (1970) Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol 11:303–314
Anden NE, Corrodi H, Fuxe K (1972) Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine-β-hydroxylase inhibitors. J Pharm Pharmacol 24:177–182
Apter A, Dickerman Z, Gonen N, Assa S, Prager-Lewin R, Kaufman H, Tyano S, Laron Z (1983) Effect of chlorpromazine on hypothalamic-pituitary-gonadal function in 10 adolescent schizophrenic boys. Am J Psychiatry 140:1588–1591
Benkert O, Klein HE, Hofschuster E, Seibold C (1981) Effect of the anticholinergic drug biperiden on pituitary hormones and cortisol. Psychoneuroendocrinology 6:231–238
Brambilla F, Guerrini A, Guastalla A, Rovere C, Riggi F (1975) Neuroendocrine effects of haloperidol therapy in chronic schizophrenia. Psychopharmacologia 44:17–22
Cass Terry L, Crowley WR, Lynch C, Longserre C, Johnson MD (1982) Role of central epinephrine in regulation of anterior pituitary hormone secretion. Peptides 3:311–318
Collu R, Jéquier JC, Leboeuf G, Letarte J, Ducharme JR (1975) Endocrine effects of pimozide, a specific dopaminergic blocker. J Clin Endocrinol Metab 41:981–984
Davis BM, Brown GM, Miller M, Friesen HG, Kastin AJ, Davis KL (1982) Effects of cholinergic stimulation on pituitary hormone release. Psychoneuroendocrinology 7:347–354
Davis JM, Vogel C, Gibbons R, Pavkovic I, Zhang M (1984) Pharmacoendocrinology of schizophrenia. In: Brown GM, Koslow SH, Reichlin S (eds) Neuroendocrinology and psychiatric disorder. Raven, New York, pp 29–53
DeRivera JL, Lal S, Ettigi P, Hontella S, Muller HF, Friesen HG (1976) Effect of acute and chronic neuroleptic therapy on serum prolactin levels in men and women of different age groups. Clin Endocrinol 5:273–282
Drouva SV, Gallo RV (1976) Catecholamine involvement in episodic luteinizing hormone release in adult ovariectomized rats. Endocrinology 99:651–658
Halbreich U, Sachar EJ, Nathan RS, Asnis GM, Halpern FS (1980) The effect of benztropine mesylate on the prolactin response to haloperidol. Psychopharmacology 72:61–65
Hanlon TE, Schoenrich C, Freinek W, Turek I, Kurland AA (1966) Perphenazine-benztropine mesylate treatment of newly admitted psychiatric patients. Psychopharmacologia 9:328–339
Kolakowska T, Wiles DH, Gelder MG, McNeilly AS (1976) Clinical significance of plasma chlorpromazine levels. Psychopharmacology 49:101–107
Krawiecka M, Goldberg D, Vaughan M (1977) A standardized psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatr Scand 55:299–308
Krulich L (1979) Central neurotransmitters and the secretion of prolactin, GH, LH and TSH. Annu Rev Physiol 41:603–615
Lal S, Mendis T, Cervantes P, Guyda H, DeRivera JL (1979) Effect of benztropine on haloperidol-induced prolactin secretion. Neuropsychobiology 5:327–331
Martin JB, Reichlin S, Brown GM (1977) Neuroendocrinology of reproduction. In: Martin JB, Reichlin S, Brown GM (eds) Clinical neuroendocrinology. Davis, Philadelphia, pp 93–128
Martin-DuPan R, Baumann P, Magrini G, Felber JP (1979) Neuroendocrine effects of chronic neuroleptic therapy in male psychiatric patients. Psychoneuroendocrinology 3:245–252
Meltzer HY (1984) Neuroendocrine abnormalities in schizophrenia: prolactin, growth hormone, and gonadotrophins. In: Brown GM, Koslow SH, Reichlin S (eds) Neuroendocrinology and psychiatric disorder. Raven, New York, pp 1–28
Nakagawa K, Obara T, Matsubara M, Kubo M (1982) Relationship of changes in serum concentrations of prolactin and testosterone during dopaminergic modulation in males. Clin Endocrinol 17:345–352
Nathan RS, Asnis GM, Dyrenfurth I, Halpern FS, Halbreich U, Ostrow LC, Sachar EJ (1980) Plasma prolactin and testosterone during penfluridol treatment. Lancet II:94
Praag HM van, Korf J (1975) Biochemical research into psychosis. Acta Psychiatr Scand 51:268–284
Rivera-Calimlim L, Castaneda L, Lasagna L (1973) Effects of mode of management on plasma chlorpromazine in psychiatric patients. Clin Pharmacol Ther 14:978–986
Rubin RT, Hays SE (1980) The prolactin secretory response to neuroleptic drugs: mechanisms, applications and limitations. Psychoneuroendocrinology 5:121–137
Rubinstein L, Sawyer CH (1970) Role of catecholamines in stimulating the release of pituitary ovulating hormones in rats. Endocrinology 86:988–995
Singh MM, Kay SR (1979) Therapeutic antagonism between anticholinergic antiparkinsonism agents and neuroleptics in schizophrenia. Neuropsychobiology 5:74–86
Siris SG, Siris ES, Kammen DP van, Docherty JP, Alexander PE, Bunney WE (1980) Effects of dopamine blockade on gonadotropins and testosterone in men. Am J Psychiatry 137:211–214
Wode-Helgodt B, Eneroth P, Fyrö B, Gullberg B, Sedvall G (1977) Effect of chlorpromazine treatment on prolactin levels in cerebrospinal fluid and plasma of psychotic patients. Acta Psychiatr Scand 56:280–293
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rinieris, P., Hatzimanolis, J., Markianos, M. et al. Effects of 4 weeks treatment with chlorpromazine and/or trihexyphenidyl on the pituitary-gonadal axis in male paranoid schizophrenics. Eur Arch Psychiatr Neurol Sci 237, 189–193 (1988). https://doi.org/10.1007/BF00449905
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00449905